Andrea Horta-Barba1,2,3,4,5, Javier Pagonabarraga6,7,8,9, Saül Martínez-Horta1,2,3,4, Laura Busteed1, Berta Pascual-Sedano1,2,3,4,5, Ignacio Illán-Gala3,4,10, Juan Marin-Lahoz1,2,3, Ignacio Aracil-Bolaños1,2,3,4, Jesús Pérez-Pérez1,2,3,4, Frederic Sampedro1,3,4, Helena Bejr-Kasem1,2,3,4,5, Jaime Kulisevsky11,12,13,14,15. 1. Movement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Mas Casanovas, 90-08041, Barcelona, Spain. 2. Universitat Autònoma de Barcelona (U.A.B.), Barcelona, Spain. 3. Institut d'Investigacions Biomèdiques- Sant Pau (IIB-Sant Pau), Barcelona, Spain. 4. Centro de Investigación en Red-Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain. 5. Faculty of Health Sciences, Universitat Oberta de Catalunya (UOC), Barcelona, Spain. 6. Movement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Mas Casanovas, 90-08041, Barcelona, Spain. jpagonabarraga@santpau.cat. 7. Universitat Autònoma de Barcelona (U.A.B.), Barcelona, Spain. jpagonabarraga@santpau.cat. 8. Institut d'Investigacions Biomèdiques- Sant Pau (IIB-Sant Pau), Barcelona, Spain. jpagonabarraga@santpau.cat. 9. Centro de Investigación en Red-Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain. jpagonabarraga@santpau.cat. 10. Memory Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. 11. Movement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Mas Casanovas, 90-08041, Barcelona, Spain. jkulisevsky@santpau.cat. 12. Universitat Autònoma de Barcelona (U.A.B.), Barcelona, Spain. jkulisevsky@santpau.cat. 13. Institut d'Investigacions Biomèdiques- Sant Pau (IIB-Sant Pau), Barcelona, Spain. jkulisevsky@santpau.cat. 14. Centro de Investigación en Red-Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain. jkulisevsky@santpau.cat. 15. Faculty of Health Sciences, Universitat Oberta de Catalunya (UOC), Barcelona, Spain. jkulisevsky@santpau.cat.
Abstract
BACKGROUND: Although several progressive supranuclear palsy (PSP) phenotypes have recently been described, studies identifying cognitive and neuropsychiatric differences between them are lacking. METHODS: An extensive battery of cognitive and behavioural assessments was administered to 63 PSP patients, 25 PD patients with similar sociodemographic characteristics, and 25 healthy controls. We analysed differences in phenomenology, frequency and severity of cognitive and neuropsychiatric symptoms between PSP, PD and HC, and between PSP subtypes. RESULTS: Regarding phenotypes, 64.6% met criteria for Richardson's syndrome (PSP-RS), 10.7% PSP with predominant Parkinsonism (PSP-P), 10.7% with PSP progressive gait freezing (PSP-PGF), and 10.7% PSP with predominant speech/language disorder (PSP-SL). Impairment was more severe in the PSP group than in the PD and HC groups regarding motor scores, cognitive testing and neuropsychiatric scales. Cognitive testing did not clearly differentiate between PSP phenotypes, but PSP-RS and PSP-SL appeared to have more cognitive impairment than PSP-PGF and PSP-P, mainly due to an increased impairment in frontal executive domains. Regarding neuropsychiatric disturbances, no specific behavior was more common in any of the PSP subtypes. CONCLUSION: Motor deficits delineate the phenotypes included in currently accepted MDS-PSP criteria. Cognition and behavioural disturbances are common in PSP and allow us to distinguish this disorder from other neurological diseases, but they do not differentiate between PSP phenotypes.
BACKGROUND: Although several progressive supranuclear palsy (PSP) phenotypes have recently been described, studies identifying cognitive and neuropsychiatric differences between them are lacking. METHODS: An extensive battery of cognitive and behavioural assessments was administered to 63 PSPpatients, 25 PDpatients with similar sociodemographic characteristics, and 25 healthy controls. We analysed differences in phenomenology, frequency and severity of cognitive and neuropsychiatric symptoms between PSP, PD and HC, and between PSP subtypes. RESULTS: Regarding phenotypes, 64.6% met criteria for Richardson's syndrome (PSP-RS), 10.7% PSP with predominant Parkinsonism (PSP-P), 10.7% with PSP progressive gait freezing (PSP-PGF), and 10.7% PSP with predominant speech/language disorder (PSP-SL). Impairment was more severe in the PSP group than in the PD and HC groups regarding motor scores, cognitive testing and neuropsychiatric scales. Cognitive testing did not clearly differentiate between PSP phenotypes, but PSP-RS and PSP-SL appeared to have more cognitive impairment than PSP-PGF and PSP-P, mainly due to an increased impairment in frontal executive domains. Regarding neuropsychiatric disturbances, no specific behavior was more common in any of the PSP subtypes. CONCLUSION: Motor deficits delineate the phenotypes included in currently accepted MDS-PSP criteria. Cognition and behavioural disturbances are common in PSP and allow us to distinguish this disorder from other neurological diseases, but they do not differentiate between PSP phenotypes.
Entities:
Keywords:
Behavior; Cognition; Motor features; PSP phenotypes; Progressive supranuclear palsy
Authors: Yasushi Osaki; Yoav Ben-Shlomo; Andrew J Lees; Susan E Daniel; Carlo Colosimo; Gregor Wenning; Niall Quinn Journal: Mov Disord Date: 2004-02 Impact factor: 10.338
Authors: Farwa Ali; Peter R Martin; Hugo Botha; J Eric Ahlskog; James H Bower; Joseph Y Masumoto; Demetrius Maraganore; Anhar Hassan; Scott Eggers; Bradley F Boeve; David S Knopman; Daniel Drubach; Ronald C Petersen; Erika Driver Dunkley; Jay van Gerpen; Ryan Uitti; Jennifer L Whitwell; Dennis W Dickson; Keith A Josephs Journal: Mov Disord Date: 2019-02-06 Impact factor: 10.338
Authors: Adam L Boxer; Jin-Tai Yu; Lawrence I Golbe; Irene Litvan; Anthony E Lang; Günter U Höglinger Journal: Lancet Neurol Date: 2017-06-13 Impact factor: 44.182
Authors: Gesine Respondek; Maria Stamelou; Carolin Kurz; Leslie W Ferguson; Alexander Rajput; Wan Zheng Chiu; John C van Swieten; Claire Troakes; Safa Al Sarraj; Ellen Gelpi; Carles Gaig; Eduardo Tolosa; Wolfgang H Oertel; Armin Giese; Sigrun Roeber; Thomas Arzberger; Stefan Wagenpfeil; Günter U Höglinger Journal: Mov Disord Date: 2014-11-05 Impact factor: 10.338
Authors: Demetris Pillas; Alexander Klein; Teresa Gasalla; Andreja Avbersek; Alexander Thompson; Jack Wright; Jennifer Mellor; Anna Scowcroft Journal: Front Neurol Date: 2022-07-04 Impact factor: 4.086